Genetic determinants of Multiple Sclerosis susceptibility in diverse ancestral backgrounds

Benjamin M. Jacobs(Queen Mary University of London), Luisa Schalk(Queen Mary University of London), Emily Tregaskis-Daniels(Queen Mary University of London), Antonio Scalfari(NIHR Imperial Biomedical Research Centre), Ashwini Nandoskar(Hillingdon Hospital), Angie Dunne(Leeds Teaching Hospitals NHS Trust), Bruno Gran(Nottingham University Hospitals NHS Trust), Charles A. Mein(Queen Mary University of London), Charlotte Sellers(Queen Mary University of London), Cord Spilker(Bradford Teaching Hospitals NHS Foundation Trust), David Rog(Northern Health and Social Care Trust), Elisa Visentin(Barking, Havering And Redbridge University Hospitals NHS Trust), Elizabeth Lindsey Bezzina(King's College - North Carolina), Emeka Uzochukwu(Cardiff University), Emma Tallantyre(University Hospital of Wales), Eva Wozniak(Queen Mary University of London), Eve Sacre(Leeds Teaching Hospitals NHS Trust), Ghaniah Hassan‐Smith(University Hospitals Birmingham NHS Foundation Trust), Helen Ford(Leeds Teaching Hospitals NHS Trust), Jade Harris(Northern Health and Social Care Trust), Joan Bradley(Hillingdon Hospital), Joshua Breedon(Queen Mary University of London), Judith Brooke(Northern Health and Social Care Trust), Karim L. Kreft(University Hospital of Wales), Katila George(Queen Mary University of London), Maria Papachatzaki, Martin O’Malley(Leeds Teaching Hospitals NHS Trust), Michelle Peter(Queen Mary University of London), Miriam Mattoscio(Barking, Havering And Redbridge University Hospitals NHS Trust), Neisha Rhule(King's College - North Carolina), Nikos Evangelou(Nottingham University Hospitals NHS Trust), Nimisha Vinod(Northern Health and Social Care Trust), Outi Quinn(Bradford Teaching Hospitals NHS Foundation Trust), Ramya Shamji(Barking, Havering And Redbridge University Hospitals NHS Trust), Rashmi Kaimal(Queen Mary University of London), Rebecca L. Boulton(Nottingham University Hospitals NHS Trust), Riffat Tanveer(Lancashire Teaching Hospitals NHS Foundation Trust), Rod Middleton(Swansea University), Roxanne Murray(Queen Mary University of London), Ruth Bellfield(Bradford Teaching Hospitals NHS Foundation Trust), Sadid Hoque(Queen Mary University of London), Shakeelah Patel(Lancashire Teaching Hospitals NHS Foundation Trust), Sonia Raj(Lancashire Teaching Hospitals NHS Foundation Trust), Stephanie Gumus, Stephanie Mitchell(Northern Health and Social Care Trust), Stephen Sawcer(Addenbrooke's Hospital), Tarunya Arun(University Hospitals Coventry and Warwickshire NHS Trust), Tatiana Pogreban(Barking, Havering And Redbridge University Hospitals NHS Trust), Terri-Louise Brown(Queen Mary University of London), Thamanna Begum(Queen Mary University of London), Veronica Antoine(Northern Health and Social Care Trust), Waqar Rashid(St George’s University Hospitals NHS Foundation Trust), Grace Fawehinmi(Barking, Havering And Redbridge University Hospitals NHS Trust), Claire Reidy(Leeds Teaching Hospitals NHS Trust), Shanaz Begum(Leeds Teaching Hospitals NHS Trust), S. Healey(Queen Mary University of London), Harriet Cummins(University Hospitals Coventry and Warwickshire NHS Trust), Kelly Westwood(University Hospitals Coventry and Warwickshire NHS Trust), Deborah Spencer(Northern Health and Social Care Trust), Shegufta Farooq(Bradford Teaching Hospitals NHS Foundation Trust), Katharine Harding(Aneurin Bevan University Health Board), Sarah Williams(Aneurin Bevan University Health Board), G. Radford(Aneurin Bevan University Health Board), Selina White(Nottingham University Hospitals NHS Trust), Nathan Alldred-Douglas(Leeds Teaching Hospitals NHS Trust), Linford Fernandes(Leeds Teaching Hospitals NHS Trust), Adil Harroud(Montreal Neurological Institute and Hospital), Jacob L. McCauley(University of Miami), Ashley Beecham(Wake Forest University), Nicolas Vince(École Centrale de Nantes), Nayane dos Santos Brito Silva(École Centrale de Nantes), Huw R. Morris(National Hospital for Neurology and Neurosurgery), Eli Silber(King's College - North Carolina), Gavin Giovannoni(Queen Mary University of London), Alastair J. Noyce(Queen Mary University of London), Ruth Dobson(Queen Mary University of London)
medRxiv
January 17, 2025
Cited by 1Open Access
Full Text

Abstract

Abstract The genetic architecture of Multiple Sclerosis (MS) susceptibility has been extensively assessed in populations of European ancestry. Greater ancestral diversity in genetic analyses of MS susceptibility is needed to improve the utility of Multiple Sclerosis genetic risk scores, fine map causal variants underlying established associations, and thereby enhance the identification of drug targets. Here we report findings from a genetic study of Multiple Sclerosis susceptibility in an ancestrally-diverse United Kingdom-based cohort. Participants with Multiple Sclerosis were recruited via clinical sites, an online platform, and through the United Kingdom Multiple Sclerosis Register. Phenotype data were gathered using a standardised questionnaire. DNA was extracted from saliva samples obtained remotely or in person, and participants were genotyped using a commercial genotyping array. Following imputation, cases were combined with controls from the United Kingdom Biobank and subjected to stringent quality control and genetic ancestry inference. We defined two broad ancestral groups of South Asian and African ancestry. We performed within-ancestry case-control genome-wide association studies of Multiple Sclerosis susceptibility using logistic models accounting for population structure and sex. We examined both single nucleotide variants and imputed classical Human Leukocyte Antigen alleles. We curated two ancestrally-matched case-control genetic datasets (South Asian ancestry: N Case =175, N Control =6744; African ancestry: N Case =113, N Control =5177). In both ancestries, we found genetic variants within the Major Histocompatibility Complex associated with Multiple Sclerosis susceptibility (South Asian ancestry: lead variant chr6:32600515:G:A on hg38 co-ordinates, Odds Ratio=1.84, nearest gene HLA-DRB1 , P= 4.6×10 −6 ; African ancestry: lead variant chr6:29919337:A:G, Odds Ratio=2.24, nearest gene HLA-A P= 4.3×10 −5 ). European-ancestry susceptibility alleles were over-represented in cases from both ancestries, with the degree of concordance stronger for the South Asian (ρ=0.31, P =8.1×10 −6 ) than African (ρ=0.1, P =0.3) ancestry cohort. European-derived genetic risk scores performed better than chance but less well than in European ancestry cohorts, explaining 1.6% (South Asian , P =1.0×10 −4 ) and 0.5% (African , P =0.08) of the liability to MS. The genetic architecture of MS susceptibility shows strong concordance across ancestral groups suggesting shared disease mechanisms. Larger studies in diverse populations are likely to enhance our understanding of how genetic variation contributes to MS susceptibility in people of all ancestral backgrounds.


Related Papers

No related papers found

Powered by citation graph analysis